Jump to navigation Jump to search
"In March 2004, he retired as Executive Vice President of pharmaceutical operations at Eli Lilly & Company after 32 years of service. He was responsible for global pharmaceutical operations and sales & marketing worldwide at Eli Lilly – a leading innovation driven corporation. Gerhard Mayr is a member of the Board of UCB since 2005 and is serving as the Chairman of UCB since 2012. He is also a member of the Board of Almirall SA (since 2012), member of the board of the Vienna Science, Research and Technology Foundation (since 2002) and a member of the board of Project Hope, USA (since 2002). He is a member of the circle of patrons of INSEAD Business School (since 2000). He has been on the Board of GVK BIO since July 2009."